Rajeev Saggar
Fortune : 11 M $ au 31/05/2026
Fortune : 11 M $ au 31/05/2026
Rajeev Saggar is currently Chief Medical Officer at Liquidia Corp.
since 2022.
Former positions include Vice President-Clinical Development at Theravance Biopharma Us LLC from 2021 to 2022, and Medical Director-Pulmonary Hypertension & Fibrosis at The Banner-University Medical Center.
Education includes a doctorate from the University of California, Irvine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,19 % | 13/04/2026 | 173 270 ( 0,19 % ) | 11 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur Technique/Scientifique/R&D | 18/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Directeur Technique/Scientifique/R&D | 01/07/2022 |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national